Read More

What’s Going On With Biofrontera Stock?

Biofrontera announced it has entered into a securities purchase agreement with healthcare-focused institutional investors led by Rosalind Advisors. Pursuant to the securities purchase agreements, the company will issue to the purchasers an aggregate $8 million in shares of the company's Series B-1 Convertible Preferred Stock.